News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Sanofi-Aventis (France) and Bristol-Myers Squibb Company Wins $442 Million Award Against Apotex Corp. Over Plavix Patent
October 20, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Sanofi-Aventis SA won a $442 million judgment against Apotex Inc. over the patent for the blood thinner Plavix, the world’s second-biggest selling drug.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
MORE ON THIS TOPIC
Pain
FDA Looks to Streamline Development of Non-Opioid Painkillers
September 11, 2025
·
2 min read
·
Tristan Manalac
CDC
Ousted CDC Director Monarez to Testify In Front of Senate After RFK Jr. Clash
September 10, 2025
·
2 min read
·
Tristan Manalac
Government
Second MAHA Report Emphasizes Chronic Disease, Tilts at Vaccine Reform
September 9, 2025
·
3 min read
·
Heather McKenzie
FDA
FDA Demurs on GLP-1 Compounding Fight, Debuts Consumer ‘Green List’ Instead
September 8, 2025
·
2 min read
·
Annalee Armstrong
